UnitedHealth CEO Working to Reassure Staff in Wake of Executive's Killing: Report
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Eli Lilly to End 2024 Among Best in Big Pharma; Novo Among Worst
Wall Street Bounces Back in Christmas Week, With S&P on Track for Banner Year
Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
Weekly Buzz: So far, Santa is Letting us Down
Can You Bet On Luigi Mangione's Fate? Betting Platforms, Regulators Wrestle With Limits In Growing Market
Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Leading And Lagging Sectors For December 27, 2024
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Markets Sluggishly Move to Year-End
Novo-Nordisk A/S faces another blow: Musk shares a weight loss photo, claiming that using Eli Lilly and Co's weight loss drug is more effective than semaglutide.
On Christmas, Musk shared a photo and called himself the Ozempic Santa Claus, clarifying that he didn't mean the drug name Ozempic for semaglutide, but rather Eli Lilly and Co's competitor Mounjaro. He also mentioned that "high doses" of Ozempic would make him fart and burp, adding that "Mounjaro seems to have fewer side effects and is more effective."
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
FDA Proposes Testing Talc Products for Asbestos: Report
Musk revealed that he switched to using Eli Lilly and Co's weight loss medication: the effect is better than Novo-Nordisk A/S's competing products, with fewer side effects.
① The world's richest man Elon Musk confirmed on the Social Media platform X on Wednesday that he is using Eli Lilly and Co's Mounjaro for weight loss; ② Musk revealed that he initially tried using Novo-Nordisk A/S's Ozempic for weight loss, but switched to Mounjaro due to significant side effects.
10 Health Care Stocks With Whale Alerts In Today's Session
Sector Update: Health Care Stocks Steady Premarket Thursday
Leading And Lagging Sectors For December 26, 2024
Elon Musk Says He Prefers Lilly's Mounjaro Over Novo's Ozempic